chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ONGOING LEFT FOOT INTERMITTENT SWELLING; ONGOING LEFT ARM LUMP OR KNOT STARTED A DAY OR SO AFTER RECEIVING THE VACCINE; UNABLE TO WALK WHEN FOOT SWELLING WAS PRESENT; TIGHTNESS DUE TO FOOT SWELLING; DISCOMFORT DUE TO FOOT SWELLING; LEFT ARM INTERMITTENT RASH STARTED ON THE SAME DAY WHEN SHE GOT VACCINATED AND WAS ONGOING; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: back problems (L4, L5), penicillin allergy, non alcohol user, and cigarette smoker (One pack per 3 days on average.), and other pre-existing medical conditions included: The patient was not a drug abuse or illicit drug user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the patient experienced ongoing left foot intermittent swelling, ongoing left arm lump or knot started a day or so after receiving the vaccine, unable to walk when foot swelling was present, tightness due to foot swelling, discomfort due to foot swelling, and left arm intermittent rash started on the same day when she got vaccinated and was ongoing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from ongoing left foot intermittent swelling, ongoing left arm lump or knot started a day or so after receiving the vaccine, left arm intermittent rash started on the same day when she got vaccinated and was ongoing, discomfort due to foot swelling, unable to walk when foot swelling was present, and tightness due to foot swelling. This report was non-serious.
Pain in right shoulder that radiates across shoulders and into left arm. Was prescribed MEDROL dose pack.
legs feel weird;started feeling strange on lt leg 18SEP95;leg felt different & has difficulty lifting foot
On 8/10/00, pt was given Tetanus booster for puncture wound on left foot with localized tetany. DOI 8/1/00 and on 8/5/00, pt began having fasciculations and cramping in the left foot. On 8/15/00, pt was having multiple generalized symptoms with neck stiffness, dysphagia, multiple muscle spasms, anxiety, photophobia, phonophobia which were progressing and is currently still having multiple symptoms. It is uncertain if symptom progression after the booster on 8/10/00 are related, but pt did have previous reaction or symptoms after Tetanus booster. Case was reported to health dept as Tetanus. The annual follow up received on 6/27/02 states improved but remains with muscle twitching and intermittent paresthesias and peripheral neuropathy sx pt is approximately 80% resolved.
The night after receiving his flu shot the patient developed red spots and hives all over his body that came and went. He also had ear swelling. Already had a cough and cold, now has coughed more. No audible wheezing or blue spells. Eating and drinking well. She is concerned this is due to the flu shot. She initially was giving him Benadryl but has not had to recently though
fever and nausea.  It went away by 9:00 AM on May 6, 2021.  I feel great now.  Actually, it was not as bad as I was prepared.  My uncle had flu like symptoms from the same vaccine for 2 days.
Itching in scalp and back of arms starting approximately 1hours after vaccination, progressing to itching at throat and redden areas 4 hours later when it was reported to employee health nurse who had administered vaccine to this employee.  Given 25mg Benadryl on recommendation of nurse clinician onsite, sent home, and advised to follow up at hospital ED if symptoms persisted or worsened.  At follow up the next day at work site, employee states she did make an ER visit and was prescribed more Benadryl and Prednisolone.  States she feels much better, but has slight headache and feels fatigued.
3/03/23 I started having pain in my right lower back and initially I thought it was a muscle spasm. The pain continued to get worse and it got so bad I began to vomit. I called an ambulance. My blood pressure was 220/114. They took me to the Emergency Room. It took 2 doses of Dilaudid to get comfortable from the pain. I had 2 CT's of my abdomen and chest. They did not find a cause, so I was sent home with a prescription for pain and nausea. The next day, the pain returned. I went back to the Emergency Room. They did another CT of my abdomen. The pain was very bad. They determined that I had inflammatory or infectious colitis. I started having profuse diarrhea while I was there which lasted a few days. They gave me antibiotics and something for intestinal cramping. I finally got better.
Extreme dizziness.  Intense headache behind eyes and down neck   Extra strength Tylenol
fever 99.1 Fahrenheit; shivers and chills; shivers and chills; body aches; Headache; dull chest pain; Fatigue; Injection site pain; This is a spontaneous report from a contactable consumer, the patient.  A 43-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK4176), via an unspecified route of administration, in the left arm on 15Jan2021 at 08:50 AM  (at the age of 43-year-old) as a single dose for COVID-19 immunization. Medical history was none. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination On 15Jan2021, the patient experienced injection site pain. On 18Jan2021, the patient experienced fever 99.1 Fahrenheit, shivers and chills, body aches, headache, dull chest pain, fatigue,. The patient had lab tests which included: 18Jan2021: pyrexia: 99.1 Fahrenheit, 19Jan2021: pyrexia: 98.9 Fahrenheit.  Treatment for the body aches included with Theraflu, and ibuprofen liquids for the headache. The clinical outcome of the event injection site pain was recovered on 16Jan2021, fever 99.1 Fahrenheit, and dull chest pain was recovered on 19Jan2021, shivers and chills was recovered on 20Jan2021. The clinical outcome of the body aches, headache, fatigue, was not recovered. It was also reported that since the vaccination, the patient had been tested for COVID-19 on 19Jan2021, the results of which was negative.
Patient came to pharmacy on 04/28/2021 for second Covid-19 vaccine shot.  She stated that 8 days after the first shot on 03/15/2021 her arm was swollen, red, and itchy.  She when to the clinic to be seen and received a prescription for triamcinolone Acetonide 0.1% cream to apply a thin layer 2 times daily for 10 days.  (prescription filled at this pharmacy on 03/23/021.
This spontaneous report as received from an office manager refers to multiple patients of unknown age and gender. There was no information about the patients' concomitant medications, allergies and pertinent medical history reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot# M033337, expiry date: 13-APR-2018, lot# M031651, expiry date: 30-FEB-2018, orally (dose was not reported). No adverse effects were reported.     The temperature was total time in the range of 9°C to 25°C for 3 hours. There was no previous temperature excursion. The call was because of data logger. Additional information has been requested. Sender's Comments: US-009507513-1703USA013727: Original Case : 1703USA013727.
Information has been received from a physician concerning a 9-week-old female who on 15-SEP-2006 was vaccinated with second mL dose of rotavirus vaccine.  The physician reported that on 16-SEP-2006, the patient developed severe diarrhea. Unspecified medical attention was sought.  No laboratory/diagnostic tests were performed. On 24-SEP-2006, the patient's diarrhea resolved.  Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of fever in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, chills, diarrhea and lethargy. On an unknown date, the outcome of the fever, chills, diarrhea and lethargy were unknown. It was unknown if the reporter considered the fever, chills, diarrhea and lethargy to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The caller said her friend had a reaction to the vaccine. Above information was all that was able to be obtained.
Initial report was received on 27 March 2013 from another manufacturer national service center (manufacturer report number 2013081062), who received the report from a health care professional. A female patient had received tetanus toxoid (manufacturer, lot number, route, site and date of administration not reported) and an unspecified amount of time later, stopped breathing. The patient's outcome was not reported. Documents held by sender: none.
she did not have much pain in her arm; sometimes feels like arm is numb; kind of like it is under anesthesia, from the site of injection until her pinky on the left side; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Apr2021 (Batch/Lot Number: Not Provided) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient did not have much pain in her arm but she sometimes felt like her arm was numb, kind of like it was under anesthesia, from the site of injection until her pinky on the left side.  It comes and goes.  Sometimes she did not feel anything, sometimes it felt numb again. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
arm was bruised / around the injection site; redness / around the injection site; pain / around the injection site; swelling, / around the injection site; hot skin around the injection site; bruising / spread / into the shoulder; bruising / spread into the axillary area; redness/ spread into the axillary area of her arm and into the shoulder; swelling, / into the axillary area of her arm and into the shoulder; pain / into the shoulder; hot feeling spread into the axillary area of her arm and into the shoulder; infection/and she was diagnosed with an; This case was reported by a consumer via call center representative and described the occurrence of injection site bruising in a 42-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number AB374, expiry date 21st November 2022) for prophylaxis.   On 29th October 2020, the patient received Boostrix (intramuscular). On 4th November 2020, 6 days after receiving Boostrix, the patient experienced infection. On an unknown date, the patient experienced injection site bruising, injection site erythema, injection site pain, injection site swelling, injection site warmth, contusion of shoulder region, axillary lump, erythema, swelling, shoulder pain and extremities hot feeling of. The patient was treated with sulfamethoxazole + trimethoprim (Bactrim). On an unknown date, the outcome of the injection site bruising, injection site erythema, injection site pain, injection site swelling, injection site warmth and infection were not recovered/not resolved and the outcome of the contusion of shoulder region, axillary lump, erythema, swelling, shoulder pain and extremities hot feeling of were unknown.   It was unknown if the reporter considered the injection site bruising, injection site erythema, injection site pain, injection site swelling, injection site warmth, infection, contusion of shoulder region, axillary lump, erythema, swelling, shoulder pain and extremities hot feeling of to be related to Boostrix.  Additional details were provided as follows: The patient received Boostrix vaccine in her left arm and within 2 days of receiving the vaccine her whole left arm was bruised, had redness, pain, swelling, and hot skin around the injection site.  The patient reported the bruising, redness, swelling, pain, and hot feeling spread into the axillary area of her arm and into the shoulder and she was diagnosed with an infection at an urgent care doctor's office.  The patient was prescribed Bactrim as a 7 day course of antibiotic for the infection.  The patient reported these events are subsiding but still ongoing currently. The reporter did not consent to follow up. The patient did not give consent to follow up with HCP because did not had a primary care doctor.
Malaise; pain at the injection site; slight fever (100F); in bed all day; Headache; Just felt tired; A spontaneous report was received from a consumer concerning a male patient who received COVID-19 (mRNA-1273) experienced fatigue, was in bed all day, slight fever, headache, malaise, and injection site pain.    The patient's medical history included Covid-19 in March 2020. Concomitant product use was not provided/unknown by the reporter  On 31 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 31 Dec 2020 that day, after he got home, he just felt tired and went to sleep. On 01 Jan 2021 he reported that he was in bed all day, had a slight fever (100 F) and headache. The next day on 02 Jan 2021, he still had some malaise in the morning, but felt better as the day progressed. He also stated that he had pain in his arm at the injection site.   Treatment for the event included paracetamol.   Action taken with mRNA-1273 in response to the events was not provided/unknown.   The outcome of the events, fatigue, was in bed all day, slight fever, headache and injection site pain were unknown and recovering for malaise.; Reporter's Comments: This case concerns a male of unknown age, with PMH of COVID-19, who had NS events of unexpected malaise and somnolence and expected pyrexia, headache, fatigue and injection site pain.  Event onset 2 days after the first dose of mRNA-1273. Treated with paracetamol. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received from a nurse practitioner, for VARIVAX (Merck) and GARDASIL, Pregnancy Registry Products, concerning a 16 year old female patient with no pertinent medical history or drug reactions/allergies who on 28-APR-2000 was vaccinated SQ with a first 0.5 mL dose of VARIVAX (Merck) (lot # not provided), on 22-MAR-2012 with a second 0.5 mL dose of VARIVAX (Merck) (lot # not provided) and on the same date with a first dose of GARDASIL (dose, route and lot # not provided). There was no concomitant medication. The nurse practitioner reported that on 09-APR-2012, the patient was found to be pregnant. There was no concomitant medication. The nurse practitioner reported that on 09-APR-2012, the patient was found to be pregnant. The patient's last menstrual period (LMP) was on 31-DEC-2011 and her estimated delivery date (EDD) was on 06-OCT-2012. Laboratory tests included prenatal blood work. The patient sought medical attention at the physician's office. No adverse effects were reported. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
On 10/25/2022, I first noticed the symptoms that evening. I started with a cough. The cough progressed on the 10/26 and 10/27. The morning of 10/27 I was going to call the doctor for cough medicine. I tested twice and got 2 positives. I called the doctor, and they sent me to their virtual dept. That afternoon I spoke to a virtual doctor. They offered PAXLOVID. I choose not to take the PAXLOVID because the symptoms were very minor. I decided to stay with the prescription cough medicine, benzonatate 100 mg and the over the counter, MUCINEX DM. I am not 100 percent. I still have a light occasional cough. A little bit of head congestion, but nothing like it was 2 or 3 days ago.
bone pain, fatigue, migraine followed by nerve pain in arms and legs, difficulty breathing, shortness of breath, gastro intestinal distress and inflammation.
My arm had minor itching for the first several days, but on Wednesday (Feb 7, 2021) after the vaccination (Feb 2, )2021, the itching intensified and was waking me up at night.  I put some anti-itch cream on it and it would quit itching for a few hours.  By Thursday, the itching was waking me up at night and by Friday afternoon, I had a half-dollar sized welt around the injection site that was very red, hard, swollen and feverish.  We weren't in school Friday, so I didn't talk to our school nurse, and today is the first day back from snow days and she advised me to fill out this report. The site is no longer bright red or itching, but you can still see the faint outline of where the swelling was.
12 hours after vaccination,  loss of consciousness, fell to ground, hit head requiring 911 emergency transport to emergency room and 13 staples to head.   Previous to fall, flu like symptoms:  fatigue, tired, muscle pain and soreness.
Information has been received from a nurse practitioner concerning a 73 year old male with a penicillin allergy who on 22-MAY-2007 was vaccinated with a first dose of Zostavax (Oka/Merck) (657675/0618U) in the left arm.  On 27-MAY-2007 (also reported as 2 days after Zostavax (Oka/Merck) injection), the patient developed a rash, erythematous patches at LUE, back and bilateral LE.  Additional information has been requested.
my arm hurt; heaviness in the chest; Anxiety; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age (age reported as "Age: 50 Unit: Unknown") received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 09Mar2021 13:45 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient took a COVID test yesterday at 7:30 in the morning, and went on the 1st shot of the vaccine in the afternoon yesterday at 13:45, the test was positive. On unspecified date in 2021, the patient's arm hurt and heaviness in the chest. The patient didn't feel badly, arm hurt from the shot and had a little bit of heaviness in the chest but  patient guesses it could be anxiety overall. The side effects last for about 1 day or longer than that. The patient underwent lab tests and procedures which included COVID test with positive result on 09Mar2021 07:30. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Patient was given the Tdap vaccine on 02/25/20 on her Left Deltoid.  Next day  02/25/20 10:30 AM, patient  called to inform Primary Care Provider that she had a reaction to the tetanus vaccine. Exacerbation of joint pain and mobility. Patient always have the fibromyalgia, but reported that morning it's worse.
Shingles symptoms began around 6/30/2021. Shingles officially diagnosed by PCP on 7/9/2021. Oral antivirals started the day of diagnosis.
Patient's doctor has advised him to wait 90 days; Contracted COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted COVID) and INTENTIONAL PRODUCT USE ISSUE (Patient's doctor has advised him to wait 90 days) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced COVID-19 (Contracted COVID). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient's doctor has advised him to wait 90 days). At the time of the report, COVID-19 (Contracted COVID) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (Patient's doctor has advised him to wait 90 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, SARS-CoV-2 test: other (Positive) Tested COVID-19 positive. On 12-Apr-2021, SARS-CoV-2 test: other (Positive) Tested positive COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-077772 (Patient Link).
Information was received from a pharmacist via a company representative concerning a 63 year old male patient with no pertinent medical history and no known drug reactions/allergies. On 19-NOV-2016, the patient was vaccinated with ZOSTAVAX 19400 PFU (lot # M018453, expiration date 28-JUN-2017), 0.65 ml, subcutaneously for shingles prevention. Concomitant therapy received the same day included TDAP. On 21-NOV-2016, the patient started to experience a "rash on his right calf and the rash was very hot to the touch."  It was also reported that the rash might have spread to the patient's neck area. No treatment was given. The outcome of the events was reported as not recovered. Additional information has been requested.
Vaccine adm. 7/21/08.  7/25/08 - developed blisters on hands, arms, neck & groin.  Called MD - Rx BENADRYL 50mg Q6H.  Saw MD on 7/28/08.  Rx-hydroxyz HCl 10mg QHS.
Patient was meant to be given the Pfizer vaccination based on current age.  No adverse effects; infectious disease provider has reviewed case and has no imminent concerns.  Patient's second dose is scheduled for 6/1 and will be receiving the Pfizer formulation.